These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3326922)

  • 21. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unchanged insulin secretion and glucose tolerance but increased insulin clearance during long-term calcium antagonism with felodipine in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    Horm Metab Res; 1987 Sep; 19(9):426-9. PubMed ID: 3319861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus.
    Jungmann E; Usadel KH
    Clin Investig; 1992 Oct; 70(10):942-8. PubMed ID: 1450619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are calcium antagonists beneficial in diabetic patients with hypertension?
    Grossman E; Messerli FH
    Am J Med; 2004 Jan; 116(1):44-9. PubMed ID: 14706665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a high-monounsaturated fat diet on glucose and lipid metabolisms in normal and diabetic mice.
    Kotake J; Tanaka Y; Umehara N; Miyashita A; Tsuru T; Hikida S; Mizote H
    J Nutr Sci Vitaminol (Tokyo); 2004 Apr; 50(2):106-13. PubMed ID: 15242014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.
    Donnelly T; Harrower AD
    Curr Med Res Opin; 1980; 6(10):690-3. PubMed ID: 7000443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
    Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
    Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of differential effects of antihypertensive agents on serum lipids.
    Brook RD
    Curr Hypertens Rep; 2000 Aug; 2(4):370-7. PubMed ID: 10981172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydropyridine calcium channel antagonists in the management of hypertension.
    Epstein BJ; Vogel K; Palmer BF
    Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition.
    Pollare T
    J Diabet Complications; 1990; 4(2):75-8. PubMed ID: 1976644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Age-related characteristics of changes in carbohydrate tolerance, the insulin allowance level and lipid metabolism].
    Grigorov IuG; Korkushko OV; Semes'ko TM; Orlov PA
    Vrach Delo; 1988 Nov; (11):50-3. PubMed ID: 3070939
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of maleate of ethyl cinepazate on the curve of the glucose tolerance test in normal subjects and subjects with altered carbohydrate metabolism].
    Petralito A; Lunetta M; Liuzzo A; Fiore CE; Mangiafico RA
    Boll Soc Ital Cardiol; 1979; 24(2):177-81. PubMed ID: 398219
    [No Abstract]   [Full Text] [Related]  

  • 38. A trial of the calcium antagonist nisoldipine in hypertensive non-insulin-dependent diabetic patients.
    Odigwe CO; McCulloch AJ; Williams DO; Tunbridge WM
    Diabet Med; 1986; 3(5):463-7. PubMed ID: 2951198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrate metabolism in hypertension: influence of treatment.
    Gambardella S; Frontoni S; Pellegrinotti M; Testa G; Spallone V; Menzinger G
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S87-97. PubMed ID: 7508068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium antagonists and glycaemic control.
    Kendall MJ; Horton RC; Chellingsworth MC
    J Clin Hosp Pharm; 1986 Jun; 11(3):175-80. PubMed ID: 3528228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.